Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer

Gynecologic Oncology

Volumn 122, Issue 3, 2011, Pages 554-559

  Ma, Xiangdong ^a   Zhang, Jianfang ^a   Liu, Shujuan ^a   Huang, Yanhong ^a   Chen, Biliang ^a   Wang, Detang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CASP8; Epithelial ovarian cancer; Genetic association; Polymorphism

Indexed keywords

CASPASE 8;

AGE; ARTICLE; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE SEVERITY; EPITHELIAL OVARY CANCER; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CASE-CONTROL STUDIES; CASPASE 8; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 80051552713     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.05.031     Document Type: Article

References (32)

1. R.M. Siegel Caspases at the crossroads of immune-cell life and death Nat Rev Immunol 6 2006 308 317
2. M.O. Hengartner The biochemistry of apoptosis Nature 407 2000 770 776
3. A. Degterev, and J. Yuan Expansion and evolution of cell death programmes Nat Rev Mol Cell Biol 9 2008 378 390 (Pubitemid 351574200)
4. R.C. Budd, W.C. Yeh, and J. Tschopp cFLIP regulation of lymphocyte activation and development Nat Rev Immunol 6 2006 196 204 (Pubitemid 43290989)
5. G. Condorelli, G. Vigliotta, A. Cafieri, A. Trencia, P. Andalo, and F. Oriente PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis Oncogene 18 1999 4409 4415 (Pubitemid 29396648)
6. Y.H. Soung, J.W. Lee, S.Y. Kim, Y.J. Sung, W.S. Park, and S.W. Nam Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225-1226delTG in hepatocellular carcinomas Oncogene 24 2005 141 147 (Pubitemid 40143873)
7. J. Takita, H.W. Yang, F. Bessho, R. Hanada, K. Yamamoto, and V. Kidd Absent or reduced expression of the caspase 8 gene occurs frequently in neuroblastoma, but not commonly in Ewing sarcoma or rhabdomyosarcoma Med Pediatr Oncol 35 2000 541 543
8. S. Palanca Suela, E. Esteban Carde osa, E. Barrag̈n Gonz̈lez, I. de Juan Jim̈nez, I. Chirivella Gonz̈lez, and Huerta Segura CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers Breast Cancer Res Treat 119 2010 87 93
9. B. Frank, K. Hemminki, B. Wappenschmidt, A. Meindl, R. Klaes, and R.K. Schmutzler Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant Carcinogenesis 27 2006 606
10. J. Lubahn, S.I. Berndt, C.H. Jin, A. Klim, J. Luly, and W.S. Wu Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma Prostate 70 2010 646 653
11. C. Li, H. Zhao, Z. Hu, Z. Liu, L.E. Wang, and J.E. Gershenwald Genetic variants and haplotypes of the caspase©\8 and caspase©\10 genes contribute to susceptibility to cutaneous melanoma Hum Mutat 29 2008 1443 1451 (Pubitemid 352774898)
12. J.W. Son, H.K. Kang, M.H. Chae, J.E. Choi, J.M. Park, and W.K. Lee Polymorphisms in the caspase-8 gene and the risk of lung cancer Cancer Genet Cytogenet 169 2006 121 127 (Pubitemid 44287103)
13. T. Sun, Y. Gao, W. Tan, S. Ma, Y. Shi, and J. Yao A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers Nat Genet 39 2007 605 613 (Pubitemid 46676113)
14. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108 (Pubitemid 40372904)
15. P.A. Fasching, S. Gayther, L. Pearce, J.M. Schildkraut, E. Goode, and F. Thiel Role of genetic polymorphisms and ovarian cancer susceptibility Mol Oncol 3 2009 171 181
16. B.B. Wolf, M. Schuler, W. Li, B. Eggers-Sedlet, W. Lee, and P. Tailor Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity J Biol Chem 276 2001 34244
17. S.J. Spencer, N.A. Cataldo, and R.B. Jaffe Apoptosis in the human female reproductive tract Obstet Gynecol Surv 51 1996 314
18. K. Satyan, N. Swamy, D.S. Dizon, R. Singh, C.O. Granai, and L. Brard Phenethyl isothiocyanate (PEITC) inhibits growth of ovarian cancer cells by inducing apoptosis: role of caspase and MAPK activation Gynecol Oncol 103 2006 261 270 (Pubitemid 44374696)
19. X. Zhang, X. Wang, X. Song, C. Liu, Y. Shi, and Y. Wang Programmed cell death 4 enhances chemosensitivity of ovarian cancer cells by activating death receptor pathway in vitro and in vivo Cancer Sci 2010
20. M. Fraser, B. Leung, A. Jahani-Asl, X. Yan, W.E. Thompson, and B.K. Tsang Chemoresistance in human ovarian cancer: the role of apoptotic regulators Reprod Biol Endocrinol 1 2003 66
21. A. Hayakawa, J. Wu, Y. Kawamoto, Y. Zhou, S. Tanuma, and I. Nakashima Activation of caspase-8 is critical for sensitivity to cytotoxic anti-Fas antibody-induced apoptosis in human ovarian cancer cells Apoptosis 7 2002 107 113 (Pubitemid 34273125)
22. M.R. Abedini, Q. Qiu, X. Yan, and B.K. Tsang Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro Oncogene 23 2004 6997 7004 (Pubitemid 39319162)
23. E.W. Duiker, A.G.J. van der Zee, P. de Graeff, Ek W. Boersma-van, H. Hollema, and G.H. de Bock The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer Gynecol Oncol 116 2010 549 555
24. J. Barrett, B. Fry, J. Maller, and M. Daly Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 2005 263
25. M. Stephens, N.J. Smith, and P. Donnelly A new statistical method for haplotype reconstruction from population data Am J Hum Genet 68 2001 978 989 (Pubitemid 32289743)
26. R. Houlston, A. Swerdlow, and M. Schoemaker CASP8 D302H and meningioma risk: an analysis of five case-control series Cancer Lett 273 2009 312 315
27. B. Frank, S.H. Rigas, J.L. Bermejo, M. Wiestler, K. Wagner, and K. Hemminki The CASP8-652 6 N del promoter polymorphism and breast cancer risk: a multicenter study Breast Cancer Res Treat 111 2008 139 144 (Pubitemid 352009221)
28. C.A. Haiman, R.R. Garcia, L.N. Kolonel, B.E. Henderson, A.H. Wu, and L. Le Marchand A promoter polymorphism in the CASP8 gene is not associated with cancer risk Nat Genet 40 2008 259 260 (Pubitemid 351311777)
29. A. Pittman, P. Broderick, K. Sullivan, S. Fielding, E. Webb, and S. Penegar CASP8 variants D302H and -652 6 N ins/del do not influence the risk of colorectal cancer in the United Kingdom population Br J Cancer 98 2008 1434 1436 (Pubitemid 351543579)
30. D. Finlay, and K. Vuori Novel noncatalytic role for caspase-8 in promoting SRC-mediated adhesion and Erk signaling in neuroblastoma cells Cancer Res 67 2007 11704
31. D. Finlay, A. Howes, and K. Vuori Critical role for caspase-8 in epidermal growth factor signaling Cancer Res 69 2009 5023
32. J. Shen, C. Behrens, I.I. Wistuba, L. Feng, J.J. Lee, and W.K. Hong Identification and validation of differences in protein levels in normal, premalignant, and malignant lung cells and tissues using high-throughput Western Array and immunohistochemistry Cancer Res 66 2006 11194